Clinical Trials Logo

Clinical Trial Summary

This is an Internet-based survey of transgender and transsexual (trans) people aged 18 years and older living in Australia. This population has received limited attention from public health researchers, planners, and practitioners. However, a growing body of evidence suggests that trans people experience disparities in several important areas of health compared with the population generally. In particular, trans people are more likely to experience mental health problems (notably depression and anxiety disorders), use alcohol, tobacco, and illicit drugs, and think about or attempt suicide. Additionally, trans people commonly report that their physical and mental health needs are not met, and underutilise preventive health care.

Participants were recruited using several non-probability sampling techniques, (including purposive sampling and snowball sampling), because random sampling is not possible with this population. Medical, social, support, and advocacy networks used by trans people were used to promote the study. A mixed quantitative and qualitative methodology was used. Validated quantitative instruments were used to obtain measures of health and well-being, which will be compared against population norms. Qualitative items complement these measures, providing rich experiential data.

The investigators hypothesised that:

- the prevalence of depressive and anxiety disorders will be higher than for the population generally, and that these conditions will commonly be undiagnosed and untreated;

- depressive and anxiety disorders will be associated with risky behaviours, such as tobacco, alcohol, and illicit drug use; and,

- trans people will report poor relationships with medical practitioners.

The investigators hypothesised that poor mental health is a consequence of several interrelated factors: body dysphoria (as a consequence of experiencing difficulty accessing medical treatment to alter sexual characteristics); societal discrimination and stigma (including harassment and violence); institutionalised discrimination (including difficulty changing identifying documents, and exclusion of surgical procedures and related treatments from public and private health systems); social isolation; and the belief held by many clinicians that transsexualism is a mental disorder (which may be a barrier to trans people forming trusting relationships with medical practitioners).


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT02119377
Study type Observational
Source Curtin University of Technology
Contact
Status Completed
Phase N/A
Start date August 2013
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT05487794 - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis N/A
Completed NCT02185274 - Observational Study on Metabolism and Psychopathology in Transsexual Patients
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Completed NCT00146146 - Testosterone and Its Metabolites in GID Phase 3
Completed NCT04864951 - HPV Prevalence in Transpersons - a Prospective Study N/A
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Completed NCT00435513 - A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism Phase 0
Recruiting NCT03637920 - Sexuality in Transmen During Hormone and Operative Treatment
Completed NCT03823014 - Use of an External Erectile Device in Transgender Man Following Phalloplasty N/A
Recruiting NCT03872648 - TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
Completed NCT01065220 - Sex Steroids and the Serotonin Transporter Phase 4
Enrolling by invitation NCT03595956 - Transgender Cohort Study of Gender Affirmation and HIV-related Health
Completed NCT02518009 - GEnder Dysphoria Treatment in Sweden
Completed NCT00135148 - Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group N/A